LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Inexpensive Multipurpose Point-of-Care Analyzer Unveiled at 2015 AACC Annual Meeting

By LabMedica International staff writers
Posted on 29 Jul 2015
An inexpensive point-of-care (POC) instrument capable of performing multiple clinical laboratory blood tests was unveiled at the 2015 AACC Annual Meeting & Clinical Lab Expo (Atlanta, GA, USA).

Investigators from DiaSys Diagnostics India (Mumbai, India) unveiled their new QDx InstaLab POC blood chemistry device. This instrument combines inexpensive microfluidic cartridge technology with novel nanomaterial-based plastic electrochemical biosensors.

The QDx InstaLab can perform all of the clinical tests that are routinely ordered as part of a yearly physical exam to evaluate organ function and check for conditions such as diabetes, liver disease, and kidney disease. Furthermore, the instrument can determine cholesterol levels and screen for bleeding problems.

The instrument was designed to perform these tests using samples comprising a few drops of blood from a finger prick. Results are available in three to 10 minutes or less.

“In areas where cost and efficiency are of paramount importance, labs will be able to consolidate all instrumentation into a single QDx InstaLab,” said Dr. Vijaywanth Mathur, head of research and development at DiaSys Diagnostics India. “This breakthrough technology will revolutionize and enable quality healthcare for all in low to middle income and high income countries, and particularly in rural, semirural, second tier, and third tier cities where there is no access to healthcare diagnostics or the cost per test is so high.”

Related Links:

2015 AACC Annual Meeting & Clinical Lab Expo
DiaSys Diagnostics India


Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining System
RAL DIFF-QUIK
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA

DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
PURITAN MEDICAL